Led by Shirley and her team, SDT Molecular envisions to be recognised as one of the foremost provider for Total Diagnostic Solutions, committing to deliver products and services of high calibre to professionals and partners in the field of clinical diagnostics.
Being certified for Good Distribution Practice for Medical Device (GDPMDS), SDT Molecular also practises in line with the Health Sciences Authority of Singapore (HSA) and Ministry of Health (MOH Biosafety) for the importation and distribution of diagnostic products and biological agents.
To meet the ever-evolving needs in the clinical diagnostic industry, SDT Molecular now offers more solutions to cover the molecular diagnostic workflow: Diagnostic Assays, Quality Controls, External Quality Assurance (EQA), Automations, Rapid Tests, Laboratory Consumables and Consultancy.
SDT Molecular’s portfolio for Diagnostic Assays has also expanded from Infectious Diseases to Genetic Testing and Food & Environment Safety Testing.
As of 2022, SDT Molecular is representing a total of at least 18 brands from all over the world, including Australia, UK, Europe, Canada and more.
SDT Molecular emphasises in delivering value-added services to its customers through its unwavering Support, Dedication and Trust. Through these company values, the, SDT Molecular has evidently built strong ties with customers including public hospitals and private laboratories, and government agencies; gaining a strong foothold in the Singapore’s molecular diagnostics field.
In addition, SDT Molecular collaborates with partners in the South-East Asia region to further expand its distribution network and will be establishing its first overseas office in Hong Kong from 2023 onwards.
For partnering opportunities within or outside Singapore, contact our CEO, Ms Tan Shirley at email@example.com.